These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25668655)

  • 1. Is there a decline in cognitive functions after combined electroconvulsive therapy and antipsychotic therapy in treatment-refractory schizophrenia?
    Pawełczyk A; Kołodziej-Kowalska E; Pawełczyk T; Rabe-Jabłońska J
    J Nerv Ment Dis; 2015 Mar; 203(3):182-6. PubMed ID: 25668655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes.
    Biedermann F; Pfaffenberger N; Baumgartner S; Kemmler G; Fleischhacker WW; Hofer A
    J ECT; 2011 Dec; 27(4):e61-2. PubMed ID: 22124226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Electroconvulsive Therapy Augmentation of Antipsychotic Treatment on Cognitive Functions in Patients With Treatment-Resistant Schizophrenia.
    Vuksan Ćusa B; Klepac N; Jakšić N; Bradaš Z; Božičević M; Palac N; Šagud M
    J ECT; 2018 Mar; 34(1):31-34. PubMed ID: 29053485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of antipsychotics with electroconvulsive therapy in treatment-resistant schizophrenia patients with dominant negative symptoms: a pilot study of effectiveness.
    Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
    Neuropsychobiology; 2014; 70(3):158-64. PubMed ID: 25358377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive therapy and clozapine in adolescents with schizophrenia spectrum disorders: is it a safe and effective combination?
    Flamarique I; Castro-Fornieles J; Garrido JM; de la Serna E; Pons A; Bernardo M; Baeza I
    J Clin Psychopharmacol; 2012 Dec; 32(6):756-66. PubMed ID: 23131877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and post-electroconvulsive therapy multidomain cognitive assessment in psychotic depression: relationship to premorbid abilities and symptom improvement.
    Bayless JD; McCormick LM; Brumm MC; Espe-Pfeifer PB; Long JJ; Lewis JL
    J ECT; 2010 Mar; 26(1):47-52. PubMed ID: 19710624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of the electroconvulsive therapy and amisulpride combination.
    Takács R; Iványi Z; Ungvari GS; Gazdag G
    Psychiatr Danub; 2013 Mar; 25(1):76-9. PubMed ID: 23470610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy versus electroconvulsive therapy for refractory schizophrenia: report of a case with 14 years of follow-up.
    Dang WM; Zhou TH; Zhou M; Luo HZ; Huang WS; Kong QM; Gao LS; Yao HP; Pang J
    Int J Psychiatry Med; 2013; 45(3):245-60. PubMed ID: 24066408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
    Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
    East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of the electroconvulsive therapy-aripiprazole combination: four case reports.
    Masdrakis VG; Oulis P; Zervas IM; Karakatsanis NA; Kouzoupis AV; Karapoulios E; Soldatos CR
    J ECT; 2008 Sep; 24(3):236-8. PubMed ID: 18562946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation Electroconvulsive Therapy for Patients With Clozapine-Resistant Schizophrenia: A Pilot Study.
    Braga RJ; John M; Schooler NR; Bailine SH; Malur C; Mendelowitz A; Petrides G
    J ECT; 2019 Sep; 35(3):156-160. PubMed ID: 30973454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive therapy and cognitive functions in treatment-resistant depression.
    Bodnar A; Krzywotulski M; Lewandowska A; Chlopocka-Wozniak M; Bartkowska-Sniatkowska A; Michalak M; Rybakowski JK
    World J Biol Psychiatry; 2016; 17(2):159-64. PubMed ID: 26482837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of clozapine and ECT: a review.
    Grover S; Hazari N; Kate N
    Acta Neuropsychiatr; 2015 Jun; 27(3):131-42. PubMed ID: 25697225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of frontal functions in psychiatric patients during maintenance electroconvulsive therapy].
    Rami-González L; Bernardo M; Portella MJ; Goti J; Gil-Verona JA; Salamero M
    Actas Esp Psiquiatr; 2003; 31(2):69-72. PubMed ID: 12677470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functions after only one ECT session: a controlled study.
    Rami L; Goti J; Ferrer J; Marcos T; Salamero M; Bernardo M
    Psychiatry Res; 2008 Apr; 158(3):389-94. PubMed ID: 18279973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study.
    Petrides G; Malur C; Braga RJ; Bailine SH; Schooler NR; Malhotra AK; Kane JM; Sanghani S; Goldberg TE; John M; Mendelowitz A
    Am J Psychiatry; 2015 Jan; 172(1):52-8. PubMed ID: 25157964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
    Tang WK; Ungvari GS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine does not increase ECT-seizure duration.
    Husni M; Haggarty J; Peat C
    Can J Psychiatry; 1999 Mar; 44(2):190-1. PubMed ID: 10097846
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.